Jiangbo Nie

457 total citations · 1 hit paper
18 papers, 313 citations indexed

About

Jiangbo Nie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiangbo Nie has authored 18 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jiangbo Nie's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (3 papers) and Bone Metabolism and Diseases (3 papers). Jiangbo Nie is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (3 papers) and Bone Metabolism and Diseases (3 papers). Jiangbo Nie collaborates with scholars based in China. Jiangbo Nie's co-authors include Mingchao Jin, Xianhao Zhou, Fengfeng Wu, Jiabao Dong, Zichen Wang, Weilai Tong, Anan Li, Zihao Liu, Jiaming Liu and Nanshan Zhong and has published in prestigious journals such as Biochemical and Biophysical Research Communications, European Journal of Pharmacology and Cell Death and Disease.

In The Last Decade

Jiangbo Nie

17 papers receiving 309 citations

Hit Papers

Mesenchymal stem cells and macrophages and their interact... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangbo Nie China 9 146 70 63 45 32 18 313
Ming Deng China 11 220 1.5× 73 1.0× 95 1.5× 32 0.7× 24 0.8× 25 386
Ziang Hu China 9 154 1.1× 64 0.9× 103 1.6× 89 2.0× 68 2.1× 29 322
Sandra Noack Germany 13 137 0.9× 69 1.0× 44 0.7× 90 2.0× 11 0.3× 28 437
Zucheng Luo China 10 193 1.3× 73 1.0× 57 0.9× 83 1.8× 64 2.0× 17 400
Fanglong Song China 11 143 1.0× 82 1.2× 46 0.7× 96 2.1× 21 0.7× 14 399
Guanqiao Liu China 10 189 1.3× 140 2.0× 47 0.7× 97 2.2× 15 0.5× 25 459
Chunshuai Wu China 12 151 1.0× 38 0.5× 69 1.1× 28 0.6× 54 1.7× 33 312
Ye Ren China 12 181 1.2× 42 0.6× 74 1.2× 60 1.3× 19 0.6× 24 342

Countries citing papers authored by Jiangbo Nie

Since Specialization
Citations

This map shows the geographic impact of Jiangbo Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangbo Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangbo Nie more than expected).

Fields of papers citing papers by Jiangbo Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangbo Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangbo Nie. The network helps show where Jiangbo Nie may publish in the future.

Co-authorship network of co-authors of Jiangbo Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangbo Nie. A scholar is included among the top collaborators of Jiangbo Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangbo Nie. Jiangbo Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nie, Jiangbo, et al.. (2025). Identifying PSIP1 as a critical R-loop regulator in osteosarcoma via machine-learning and multi-omics analysis. Cancer Cell International. 25(1). 159–159. 1 indexed citations
2.
Tong, Weilai, Xinsheng Xie, Jiangbo Nie, et al.. (2025). SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10. Journal of Translational Medicine. 23(1). 220–220.
3.
Li, Anan, Shijiang Wang, Jiangbo Nie, et al.. (2024). USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway. Cell Death and Disease. 15(3). 235–235. 9 indexed citations
4.
Nie, Jiangbo, Jia Yao, Jianxin Wang, et al.. (2024). Genomic survey and expression analysis of cellulose synthase superfamily and COBRA-like gene family in Zanthoxylum bungeanum stipule thorns. Physiology and Molecular Biology of Plants. 30(3). 369–382. 4 indexed citations
5.
Wang, Shijiang, Jiangbo Nie, Anan Li, et al.. (2024). VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. Cell Death and Disease. 15(11). 788–788. 6 indexed citations
6.
Zhang, Xueli, Jiangbo Nie, Shengshu Wang, et al.. (2024). Genome-Wide Identification and Characterization of bHLH Transcription Factors in Zanthoxylum bungeanum and Their Expression Analysis in Response to Salt Stress. Plant Molecular Biology Reporter. 43(2). 847–861. 1 indexed citations
7.
Jin, Mingchao, et al.. (2023). Mesenchymal stem cells and macrophages and their interactions in tendon-bone healing. Journal of Orthopaedic Translation. 39. 63–73. 72 indexed citations breakdown →
8.
Zhou, Ling, et al.. (2023). Codon usage bias and genetic diversity in chloroplast genomes of Elaeagnus species (Myrtiflorae: Elaeagnaceae). Physiology and Molecular Biology of Plants. 29(2). 239–251. 15 indexed citations
9.
Nie, Jiangbo, Yuhang Ling, Mingchao Jin, et al.. (2023). Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3/SLC7A11 pathway. European Journal of Pharmacology. 957. 176009–176009. 21 indexed citations
10.
Liu, Zihao, Anan Li, Weilai Tong, et al.. (2023). Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury. CNS Neuroscience & Therapeutics. 29(4). 1094–1108. 62 indexed citations
11.
Tong, Weilai, Shijiang Wang, Cheng He, et al.. (2023). CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. Journal of Cancer. 14(6). 916–926. 8 indexed citations
12.
Wang, Shijiang, Jiangbo Nie, Yang Liu, et al.. (2023). YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B. Aging. 15(18). 9590–9613. 11 indexed citations
13.
Nie, Jiangbo, Ning Liu, Xinhua Long, et al.. (2023). Identification and experimental validation of Stearoyl-CoA desaturase is a new drug therapeutic target for osteosarcoma. European Journal of Pharmacology. 963. 176249–176249. 5 indexed citations
14.
Wu, Fengfeng, Juntao Xu, Mingchao Jin, et al.. (2022). Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma. Frontiers in Molecular Biosciences. 8. 705148–705148. 9 indexed citations
15.
Jin, Mingchao, Jiangbo Nie, Jing Li, et al.. (2021). Acacetin inhibits RANKL-induced osteoclastogenesis and LPS-induced bone loss by modulating NFATc1 transcription. Biochemical and Biophysical Research Communications. 583. 146–153. 10 indexed citations
16.
Zhou, Xianhao, et al.. (2021). Correction to: Molecular mechanisms of mechanical load-induced osteoarthritis. International Orthopaedics. 45(6). 1661–1661. 1 indexed citations
17.
Zhou, Xianhao, et al.. (2021). Molecular mechanisms of mechanical load-induced osteoarthritis. International Orthopaedics. 45(5). 1125–1136. 75 indexed citations
18.
Xu, Juntao, Mingchao Jin, Xuesheng Jiang, et al.. (2020). Coating of Epimedii Folium Water Extract onto TiO2 Nanotube Surfaces Promotes Differentiation and Proliferation of Osteoblasts. Journal of Biomedical Nanotechnology. 16(6). 885–898. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026